Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Afghanistan receives second shipment of COVID-19 vaccines through the COVAX Facility | WHO |

Kabul, Afghanistan, 9 July 2021 - Today, Afghanistan received 1.48 million doses of Johnson & Johnson vaccine through the COVAX Facility. 

This delivery is the first of 2 shipments of a total of 3 312 100 doses of Johnson & Johnson vaccine allocated to Afghanistan through the COVAX Facility, with the remaining doses set to arrive later this month. 
The shipment of vaccine received today comes in addition to the first batch of 468 000 doses of the COVISHIELD (AstraZeneca) vaccine, delivered in March 2021 through the COVAX Facility, a partnership between CEPI, Gavi - the Vaccine Alliance, UNICEF and WHO.

"This shipment comes at a critical time when the country is experiencing a third wave and a continuous rise in COVID-19 cases. The doses received will be vital in boosting and scaling up Afghanistan's ongoing COVID-19 vaccination programme led by the Ministry of Public Health," said Dr Irfan Akbar Elahi, Officer In Charge, WHO Afghanistan.

Ensuring the safety and effectiveness of vaccines remains a prime focus for WHO. The Johnson & Johnson vaccine, which is a single dose vaccine, has been approved for emergency use listing by WHO and has already been rolled out in various countries. "We urge everyone to vaccinate to keep themselves and their communities safe. Vaccines are a key tool for stopping the spread of COVID-19," said Dr Elahi.  

Apart from vaccines delivered through the COVAX Facility, Afghanistan has also received 500 000 doses of the AstraZeneca vaccine donated by India and 700 000 doses of Sinopharm donated by China.

'Sapere aude'
by Oui (Oui) on Sun Aug 29th, 2021 at 06:07:39 PM EST
[ Parent ]

Others have rated this comment as follows:

Cat 4


Occasional Series